Estimation of Anti-Tubercular Drug Resistance in Relapse TB Patients in Rims Hospital, Srikakulam
Received Date: Mar 18, 2019 / Accepted Date: May 10, 2019 / Published Date: May 21, 2019
Abstract
Relapse TB means the patient had a TB he was previously been treated for TB. Most of such patients had Multi-Drug resistance for first line TB treatment. Method and Materials: These studies were conducted based on observational study in this study we utilized quantitative method to find an effected population. Result: we gathered total 150 population in the period of six months in that 63 individuals were sent for CBNAT test (Rifampicin Resistant test) out of that 40 samples were got a positive results to Rifampicin Resistant, in that male 36 (57.1%) were higher than females 4(6.3%) and adults 31(49.2%) were more than the other age groups, based on the location Srikakulam zone were higher than the other zones. Conclusion: Relapse TB and Multidrug resistant caused due to failure of TB treatment, infected with drug resistant mycobacteria.
Keywords: Relapse Tb; Cartridge Based Nucleic Acid AmplificationTest (Cbnaat); Drug Resistance; Dot; Treatment; Acid Fast Bacilli; Dst;Drt; Patient
Citation: Allu H, Mudakala S, Singupuram M, Kaviti US (2019) Estimation of Anti-Tubercular Drug Resistance in Relapse TB Patients in Rims Hospital, Srikakulam. J Infect Dis Ther 7: 404. Doi: 10.4172/2332-0877.1000404
Copyright: © 2019 Allu H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 2476
- [From(publication date): 0-2019 - Feb 23, 2025]
- Breakdown by view type
- HTML page views: 1870
- PDF downloads: 606
